Literature DB >> 26549780

Comorbidities of epilepsy: current concepts and future perspectives.

Mark R Keezer1, Sanjay M Sisodiya1, Josemir W Sander2.   

Abstract

The burden of comorbidity in people with epilepsy is high. Several diseases, including depression, anxiety, dementia, migraine, heart disease, peptic ulcers, and arthritis are up to eight times more common in people with epilepsy than in the general population. Several mechanisms explain how epilepsy and comorbidities are associated, including shared risk factors and bidirectional relations. There is a pressing need for new and validated screening instruments and guidelines to help with the early detection and treatment of comorbid conditions. Preliminary evidence suggests that some conditions, such as depression and migraine, negatively affect seizure outcome and quality of life. Further investigation is needed to explore these relations and the effects of targeted interventions. Future advances in the investigation of the comorbidities of epilepsy will strengthen our understanding of epilepsy and could play an important part in stratification for genetic studies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26549780     DOI: 10.1016/S1474-4422(15)00225-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  101 in total

1.  Drug-resistant epilepsy, early-onset hypertension and white matter lesions: a hidden paraganglioma.

Authors:  Katri Silvennoinen; Alison J Waghorn; Simona Balestrini; Sanjay M Sisodiya
Journal:  BMJ Case Rep       Date:  2019-06-21

Review 2.  Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults.

Authors:  Linda J Stephen; Martin J Brodie
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

3.  Computer-assisted planning for the insertion of stereoelectroencephalography electrodes for the investigation of drug-resistant focal epilepsy: an external validation study.

Authors:  Vejay N Vakharia; Rachel Sparks; Roman Rodionov; Sjoerd B Vos; Christian Dorfer; Jonathan Miller; Daniel Nilsson; Martin Tisdall; Stefan Wolfsberger; Andrew W McEvoy; Anna Miserocchi; Gavin P Winston; Aidan G O'Keeffe; Sebastien Ourselin; John S Duncan
Journal:  J Neurosurg       Date:  2018-04-01       Impact factor: 5.115

4.  Disease-Modification in Epilepsy by Nonpharmacological Methods.

Authors:  Nigel C Jones
Journal:  Epilepsy Curr       Date:  2018 Jan-Feb       Impact factor: 7.500

5.  Depression Screening Tools: More Hammers, Fewer Nails.

Authors:  Jay Salpekar
Journal:  Epilepsy Curr       Date:  2018 Jan-Feb       Impact factor: 7.500

6.  The intriguing relationship between epilepsy and type 1 diabetes mellitus. Reply to Sander JW, Novy J, Keezer MR [letter].

Authors:  I-Ching Chou; Chia-Hung Kao
Journal:  Diabetologia       Date:  2016-05-18       Impact factor: 10.122

7.  The intriguing relationship between epilepsy and type 1 diabetes mellitus.

Authors:  Josemir W Sander; Jan Novy; Mark R Keezer
Journal:  Diabetologia       Date:  2016-05-18       Impact factor: 10.122

8.  Trends in oral anticoagulant co-prescription with antiepileptic drugs among adults with epilepsy, 2010-2018.

Authors:  Emily K Acton; Michael A Gelfand; Sean Hennessy; Sharon X Xie; John R Pollard; Scott E Kasner; Allison W Willis
Journal:  Epilepsy Behav       Date:  2020-11-24       Impact factor: 2.937

9.  Global enhancement of cortical excitability following coactivation of large neuronal populations.

Authors:  Deng Zhang; Xingjian Yan; Liang She; Yunqing Wen; Mu-Ming Poo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

10.  Adults with an epilepsy history, notably those 45-64 years old or at the lowest income levels, more often report heart disease than adults without an epilepsy history.

Authors:  Matthew Zack; Cecily Luncheon
Journal:  Epilepsy Behav       Date:  2018-06-13       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.